[The use of the cephalosporin antibiotic Zinnat under polyclinic conditions in treating patients with bronchopulmonary infections].
The cephalosporin antibiotic zinnat was given to 171 outpatients with bronchopulmonary infections. Pneumonia patients received 500 mg, patients with acute bronchitis or exacerbation of chronic bronchitis 250 mg twice a day. The recovery was registered in 97.7, 98.8 and 91.8% of patients, respectively. The drug proved effective, low-toxic, convenient in use. Wide-spectrum action, significant activity against both gram-positive and gram-negative pathogens make zinnat a promising drug for outpatient treatment of bronchopulmonary infections.
Bart
B Ia
BIa
Solov'ev
S S
SS
Zaseeva
O V
OV
Benevskaia
V F
VF
Mikhaĭlusova
M P
MP
Romanova
M V
MV
Kasatikova
L A
LA
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000553:Ambulatory Care; D001991:Bronchitis / Q000175:diagnosis / Q000188:drug therapy*; D002444:Cefuroxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000188:drug therapy*; D011355:Prodrugs / Q000009:adverse effects / Q000627:therapeutic use*
D002511:Cephalosporins; D011355:Prodrugs; D002444:Cefuroxime; C040738:cefuroxime axetil
Primenenie tsefalosporinovogo antibiotika zinnata v poliklinicheskikh usloviiakh pri lechenii bol'nykh s bronkholegochnymi infektsiiami.